Switzerland has thriving science-based industry, comprised of world-class firms in the pharmaceutical, chemical and biotechnology sectors. It is estimated that the Swiss pharmaceutical industry alone accounts for over 11% of the country’s exports and for nearly 6% of its GDP. These high-value industries are backed by a strong R&D sector, which currently benefits from one of the world’s highest governmental budget allocations. Basel-based PreClinical Safety (PCS) Consultants Ltd. is a successful player in this field.
Webcode:
To read an article from the print magazine online, please enter the web code below, which can be found in the magazine under the article.
